CellaVision AB a un dividende annuel de 2.25 par action, avec un rendement de 0.00%. Le dividende est payé annuellement et la dernière date d'ex-dividende était le May 7, 2025.
Rendement en dividend
Dividende annuel
Date ex-dividende
0.00%
$2.25
May 7, 2025
Fréquence des paiements
Taux de distribution
Annuellement
0.00%
Historique des dividendes
Date ex-dividende
Montant en espèces
Date de registre
Date de paiement
May 7, 2025
$2.50
May 8, 2025
May 13, 2025
May 6, 2024
$2.25
May 7, 2024
May 13, 2024
May 8, 2023
$2.25
May 9, 2023
May 12, 2023
May 12, 2022
$2.00
May 13, 2022
May 18, 2022
Apr 30, 2021
$0.75
May 3, 2021
May 6, 2021
May 9, 2019
$1.50
May 10, 2019
May 15, 2019
Graphiques des dividendes
CVLLY Dividendes
CVLLY Croissance des dividendes (variation annuelle)
Follow-Up Questions
Quel est le dividende actuel payé par CellaVision AB et son dividende annuel ?
Quel est le ratio de distribution de dividendes de CellaVision AB ?
Quelle est la date ex-dividende pour CVLLY ?
À quelle fréquence CellaVision AB verse-t-elle des dividendes ?
Statistiques clés
Clôture préc.
--
Prix d'ouverture
--
Plage de la journée
-
Plage de 52 semaines
-
Volume
--
Volume moyen
--
BPA (TTM)
--
Rendement en dividend
--
Capitalisation boursière
--
Qu’est-ce que CVLLY ?
CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The company is headquartered in Lund, Skane and currently employs 230 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.